EU biotech champions struggle with finance, says Euronext Brussels CEO

21-05-2026

EURACTIV - Benoît van den Hove tells Euractiv that scaling biotech companies at a global level still depends on capital that Europe does not yet mobilise at sufficient scale. Read more

Euronext Brussels CEO Benoît van den Hove

 

Share